Do Analysts Expect Avalo Therapeutics Inc (AVTX) Stock to Rise After It Is Down -34.07% in a Month?

Wall Street is positive on Avalo Therapeutics Inc (AVTX). On average, analysts give the stock a Buy rating. The average price target is $11.333, which means analysts expect the stock to climb by 536.69% over the next twelve months.That average ranking earns the stock an Analyst Rating of 21, which is better than 21% of sto